Global dibigatran Market Research Report to 2021

October 2016 | 101 pages | ID: GB006A1863FEN
QYResearch

Abstracts

Notes:

Production, means the output of dibigatran

Revenue, means the sales value of dibigatran

This report studies dibigatran in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of dibigatran in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of dibigatran in each application, can be divided into

• stroke
• deep vein thrombosis
• pulmonary embolism
• systemic embolism

Contents

Global dibigatran Market Research Report 2021

1 DIBIGATRAN OVERVIEW

1.1 Product Overview and Scope of dibigatran
1.2 dibigatran Segment by Types
  1.2.1 Global Production Market Share of dibigatran by Type in 2015
  1.2.2 Type I Overview and Price
    1.2.2.1 Type I Overview
    1.2.2.2 Type I Price List in 2015 and 2016
  1.2.3 Type II
    1.2.3.1 Type I Overview
    1.2.3.2 Type I Price List in 2015 and 2016
  1.2.4 Type III
    1.2.4.1 Type I Overview
    1.2.4.2 Type I Price List in 2015 and 2016
1.3 dibigatran Segment by Application
  1.3.1 dibigatran Consumption Market Share by Application in 2015
  1.3.2 stroke and Major Clients (Buyers) List
  1.3.3 deep vein thrombosis and Major Clients (Buyers) List
  1.3.4 pulmonary embolism and Major Clients (Buyers) List
  1.3.5 systemic embolism and Major Clients (Buyers) List
1.4 dibigatran Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of dibigatran (2011-2021)
  1.5.1 Global dibigatran Production and Revenue (2011-2021)
  1.5.2 Global dibigatran Production and Growth Rate (2011-2021)
  1.5.3 Global dibigatran Revenue and Growth Rate (2011-2021)

2 GLOBAL DIBIGATRAN MARKET COMPETITION BY MANUFACTURERS

2.1 Global dibigatran Production and Share by Manufacturers (2015 and 2016)
2.2 Global dibigatran Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global dibigatran Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers dibigatran Manufacturing Base Distribution and Product Type
2.5 Competitive Situation and Trends
  2.5.1 Expansions
  2.5.2 New Product Launches
  2.5.3 Acquisitions
  2.5.4 Other Developments

3 GLOBAL DIBIGATRAN ANALYSIS BY REGION

3.1 Global dibigatran Production, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global dibigatran Production Market Share by Region (2011-2021)
  3.1.2 Global dibigatran Revenue Market Share by Region (2011-2021)
3.2 Global dibigatran Consumption by Region (2011-2021)
3.3 North America
  3.3.1 North America dibigatran Production, Revenue and Price (2011-2021)
  3.3.2 North America dibigatran Production, Revenue and Growth Rate (2011-2021)
3.4 Europe
  3.4.1 Europe dibigatran Production, Revenue and Price (2011-2021)
  3.4.2 Europe dibigatran Production, Revenue and Growth Rate (2011-2021)
3.5 China
  3.5.1 China dibigatran Production, Revenue and Price (2011-2021)
  3.5.2 China dibigatran Production, Revenue and Growth Rate (2011-2021)
3.6 Japan
  3.6.1 Japan dibigatran Production, Revenue and Price (2011-2021)
  3.6.2 Japan dibigatran Production, Revenue and Growth Rate (2011-2021)
3.7 India
  3.7.1 India dibigatran Production, Revenue and Price (2011-2021)
  3.7.2 India dibigatran Production, Revenue and Growth Rate (2011-2021)
3.8 Southeast Asia
  3.8.1 Southeast Asia dibigatran Production, Revenue and Price (2011-2021)
  3.8.2 Southeast Asia dibigatran Production, Revenue and Growth Rate (2011-2021)

4 GLOBAL DIBIGATRAN ANALYSIS BY TYPE

4.1 Global dibigatran Production, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global dibigatran Production and Market Share by Type (2011-2021)
  4.1.2 Global dibigatran Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type I Production, Revenue, Price and Growth (2011-2021)
4.3 Type II Production, Revenue, Price and Growth (2011-2021)
4.4 Type III Production, Revenue, Price and Growth (2011-2021)

5 GLOBAL DIBIGATRAN MARKET ANALYSIS BY APPLICATION

5.1 Global dibigatran Consumption and Market Share by Application (2011-2021)
5.2 Major Regions dibigatran Consumption by Application in 2015 and 2016
  5.2.1 North America dibigatran Consumption by Application
  5.2.2 Europe dibigatran Consumption by Application
  5.2.3 China dibigatran Consumption by Application
  5.2.4 Japan dibigatran Consumption by Application
  5.2.5 India dibigatran Consumption by Application
  5.2.6 Southeast Asia dibigatran Consumption by Application
5.3 Global dibigatran Consumption Growth Rate by Application (2011-2021)
5.4 Market Drivers and Opportunities
  5.4.1 Potential Applications
  5.4.2 Emerging Markets/Countries

6 GLOBAL DIBIGATRAN MANUFACTURERS ANALYSIS

6.1 Pfizer, Inc. (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 dibigatran Product Type and Technology
    6.1.2.1 Type I
    6.1.2.2 Type II
    6.1.2.3 Type III
  6.1.3 Machinery & Equipment Production, Revenue, Price of dibigatran (2015 and 2016)
6.2 Bayer Healthcare AG (Germany)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 dibigatran Product Type and Technology
    6.2.2.1 Type I
    6.2.2.2 Type II
    6.2.2.3 Type III
  6.2.3 Bayer Healthcare AG (Germany) Production, Revenue, Price of dibigatran (2015 and 2016)
6.3 GlaxoSmithKline Plc. (UK)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 dibigatran Product Type and Technology
    6.3.2.1 Type I
    6.3.2.2 Type II
    6.3.2.3 Type III
  6.3.3 GlaxoSmithKline Plc. (UK) Production, Revenue, Price of dibigatran (2015 and 2016)
6.4 Boehringer Ingelheim (Germany)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 dibigatran Product Type and Technology
    6.4.2.1 Type I
    6.4.2.2 Type II
  6.4.3 Boehringer Ingelheim (Germany) Production, Revenue, Price of dibigatran (2015 and 2016)
6.5 Sanofi S.A. (France)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 dibigatran Product Type and Technology
    6.5.2.1 Type I
    6.5.2.2 Type II
  6.5.3 Sanofi S.A. (France) Production, Revenue, Price of dibigatran (2015 and 2016)
6.6 Abbott India Limited (India)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 dibigatran Product Type and Technology
    6.6.2.1 Type I
    6.6.2.2 Type II
  6.6.3 Abbott India Limited (India) Production, Revenue, Price of dibigatran (2015 and 2016)
6.7 Aspen Holdings (South Africa)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 dibigatran Product Type and Technology
    6.7.2.1 Type I
    6.7.2.2 Type II
  6.7.3 Aspen Holdings (South Africa) Production, Revenue, Price of dibigatran (2015 and 2016)
6.8 Bristol-Myers Squibb Company (US)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 dibigatran Product Type and Technology
    6.8.2.1 Type I
    6.8.2.2 Type II
  6.8.3 Bristol-Myers Squibb Company (US) Production, Revenue, Price of dibigatran (2015 and 2016)
6.9 Eisai Inc. (US)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 dibigatran Product Type and Technology
    6.9.2.1 Type I
    6.9.2.2 Type II
  6.9.3 Eisai Inc. (US) Production, Revenue, Price of dibigatran (2015 and 2016)
6.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 dibigatran Product Type and Technology
    6.10.2.1 Type I
    6.10.2.2 Type II
  6.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Production, Revenue, Price of dibigatran (2015 and 2016)
6.11 Teva Pharmaceutical Industries Ltd. (Israel)

7 DIBIGATRAN TECHNOLOGY AND DEVELOPMENT TREND

7.1 dibigatran Technology Analysis
7.2 dibigatran Technology Development Trend

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of dibigatran
Figure Global Production Market Share of dibigatran by Type in 2015
Table dibigatran Product Types of by Manufacturers
Figure Product Picture of Type I
Table Type I Price List in 2015 and 2016
Figure Product Picture of Type II
Table Type II Price List in 2015 and 2016
Figure Product Picture of Type III
Table Type III Price List in 2015 and 2016
Table dibigatran Consumption Market Share by Applications in 2015 and 2016
Table dibigatran Major Clients (Buyers) List in stroke
Table dibigatran Major Clients (Buyers) List in deep vein thrombosis
Table dibigatran Major Clients (Buyers) List in pulmonary embolism
Table dibigatran Major Clients (Buyers) List in systemic embolism
Figure North America dibigatran Production and Growth Rate (2011-2021)
Figure North America dibigatran Consumption and Growth Rate (2011-2021)
Figure China dibigatran Production and Growth Rate (2011-2021)
Figure China dibigatran Consumption and Growth Rate (2011-2021)
Figure Europe dibigatran Production and Growth Rate (2011-2021)
Figure Europe dibigatran Consumption and Growth Rate (2011-2021)
Figure Japan dibigatran Production and Growth Rate (2011-2021)
Figure Japan dibigatran Consumption and Growth Rate (2011-2021)
Figure India dibigatran Production and Growth Rate (2011-2021)
Figure India dibigatran Consumption and Growth Rate (2011-2021)
Figure Southeast Asia dibigatran Production and Growth Rate (2011-2021)
Figure Southeast Asia dibigatran Consumption and Growth Rate (2011-2021)
Table Global dibigatran Production and Revenue (2011-2021)
Figure Global dibigatran Production and Growth Rate (2011-2021)
Figure Global dibigatran Revenue and Growth Rate (2011-2021)
Table Global dibigatran Production of Key Manufacturers (2015 and 2016)
Table Global dibigatran Production Share by Manufacturers (2015 and 2016)
Figure 2015 dibigatran Production Share by Manufacturers
Figure 2016 dibigatran Production Share by Manufacturers
Table Global dibigatran Revenue by Manufacturers (2015 and 2016)
Table Global dibigatran Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global dibigatran Revenue Share by Manufacturers
Table 2016 Global dibigatran Revenue Share by Manufacturers
Table Global Market dibigatran Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers dibigatran Manufacturing Base Distribution and Product Type
Table Global dibigatran Production Market by Region (2011-2021)
Figure Global dibigatran Production Market by Region (2011-2021)
Figure Global dibigatran Production Market Share by Region (2011-2021)
Table Global dibigatran Revenue Market by Region (2011-2021)
Table Global dibigatran Revenue Market Share by Region (2011-2021)
Table Global dibigatran Consumption Market by Region (2011-2021)
Table Global dibigatran Consumption Market Share by Region (2011-2021)
Figure Global dibigatran Consumption Market Share by Region (2011-2021)
Table North America dibigatran Production, Revenue and Price (2011-2021)
Figure North America dibigatran Production, Revenue and Growth Rate (2011-2021)
Table Europe dibigatran Production, Revenue and Price (2011-2021)
Figure Europe dibigatran Production, Revenue and Growth Rate (2011-2021)
Table China dibigatran Production, Revenue and Price (2011-2021)
Figure China dibigatran Production, Revenue and Growth Rate (2011-2021)
Table Japan dibigatran Production, Revenue and Price (2011-2021)
Figure Japan dibigatran Production, Revenue and Growth Rate (2011-2021)
Table India dibigatran Production, Revenue and Price (2011-2021)
Figure India dibigatran Production, Revenue and Growth Rate (2011-2021)
Table Southeast Asia dibigatran Production, Revenue and Price (2011-2021)
Figure Southeast Asia dibigatran Production, Revenue and Growth Rate (2011-2021)
Table Global dibigatran Production by Type (2011-2021)
Table Global dibigatran Production Share by Type (2011-2021)
Figure Production Market Share of dibigatran by Type (2011-2021)
Figure Global dibigatran Production Growth Rate by Type (2011-2021)
Table Global dibigatran Revenue by Type (2011-2021)
Table Global dibigatran Revenue Share by Type (2011-2021)
Figure Global dibigatran Revenue Growth Rate by Type (2011-2021)
Figure Type I Production, Revenue and Growth (2011-2021)
Figure Type I Price Trend (2011-2021)
Figure Type II Production, Revenue and Growth (2011-2021)
Figure Type II Price Trend (2011-2021)
Figure Type III Production, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global dibigatran Consumption by Application (2011-2021)
Table Global dibigatran Consumption Market Share by Application (2011-2021)
Figure Global dibigatran Consumption Market Share by Application in 2015
Figure Global dibigatran Consumption Market Share by Application in 2021
Table North America dibigatran Consumption by Application (2015 and 2016)
Table Europe dibigatran Consumption by Application (2015 and 2016)
Table China dibigatran Consumption by Application (2015 and 2016)
Table Japan dibigatran Consumption by Application (2015 and 2016)
Table India dibigatran Consumption by Application (2015 and 2016)
Table Southeast Asia dibigatran Consumption by Application (2015 and 2016)
Table Global dibigatran Consumption Growth Rate by Application (2011-2021)
Figure Global dibigatran Consumption Growth Rate by Application (2011-2021)
Table Pfizer, Inc. (US) Basic Information List
Table dibigatran Production, Revenue, Price of Pfizer, Inc. (US) (2015 and 2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table dibigatran Production, Revenue, Price of Bayer Healthcare AG (Germany) (2015 and 2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table dibigatran Production, Revenue, Price of GlaxoSmithKline Plc. (UK) (2015 and 2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table dibigatran Production, Revenue, Price of Boehringer Ingelheim (Germany) (2015 and 2016)
Table Sanofi S.A. (France) Basic Information List
Table dibigatran Production, Revenue, Price of Sanofi S.A. (France) (2015 and 2016)
Table Abbott India Limited (India) Basic Information List
Table dibigatran Production, Revenue, Price of Abbott India Limited (India) (2015 and 2016)
Table Aspen Holdings (South Africa) Basic Information List
Table dibigatran Production, Revenue, Price of Aspen Holdings (South Africa) (2015 and 2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table dibigatran Production, Revenue, Price of Bristol-Myers Squibb Company (US) (2015 and 2016)
Table Eisai Inc. (US) Basic Information List
Table dibigatran Production, Revenue, Price of Eisai Inc. (US) (2015 and 2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table dibigatran Production, Revenue, Price of Mitsubishi Tanabe Pharma Corporation (Japan) (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table dibigatran Production, Revenue, Price of Teva Pharmaceutical Industries Ltd. (Israel) (2015 and 2016)